News | February 07, 2022
Serum receives green light for Omicron variant vaccine
Pfizer and Moderna are also working on vaccines that target the Omicron variant
Pfizer and Moderna are also working on vaccines that target the Omicron variant
Clarithromycin tablets USP, 250 mg and 500 mg have an estimated market size of US $ 11 million for twelve months ending September 2021 according to IQVIA
Prof Karikó's research was most notably used by Pfizer/BioNTech and Moderna to build COVID-19 mRNA vaccines
It provides Covid-19 detection and Omicron surveillance in less than two hours
In-house wet testing with live Omicron virus demonstrated that the Antigen test detects the Omicron variant with comparable sensitivity to other variants
New data from ongoing trial showed increased antibody response against Beta, Delta, Alpha, Gamma and Omicron variants following third dose booster with Vaxzevria
This test analyses samples in VTM directly without the need for RNA extraction step
The study will be published on the pre-print server, medRXiv, shortly
Carisma to receive US $ 45 million up-front cash payment and investment by Moderna in the form of a US $ 35 million convertible note
Despite the challenges of pandemic disruptions, drug developers advance promising therapies for conditions, including Alzheimer's, diabetes and asthma
Subscribe To Our Newsletter & Stay Updated
